Heron Therapeutics, Inc.

Healthcare

NASDAQ:HRTX · NASDAQ Capital Market

Market Cap $61.17M Beta 1.57 P/E (TTM) -2.5

$0.42 +3.74%

+$0.01 today

52W Low $0.38High $2.30

Vol 5.46M · Avg 2.90M

EPS (TTM) -$0.16Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-80.21%

Period High

$2.23

Period Low

$0.38

Latest

$0.42

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

SELLAS Life Sciences Group, Inc.

NASDAQ:SLS

$1.19B

Genfit S.A.

GNFT

$445.68M

OmniAb, Inc.

NASDAQ:OABI

$267.42M

Eupraxia Pharmaceuticals Inc.

NASDAQ:EPRX

$212.10M

Coherus Oncology, Inc.

NASDAQ:CHRS

$174.43M

Protalix BioTherapeutics, Inc.

AMEX:PLX

$170.41M

Protara Therapeutics, Inc.

NASDAQ:TARA

$155.32M

MediWound Ltd.

NASDAQ:MDWD

$153.38M

Invivyd, Inc.

NASDAQ:IVVD

$124.75M

Neonc Technologies Holdings, Inc.

NASDAQ:NTHI

$99.78M

What is the latest HRTX filing?

The latest filing shown is 4 dated Jun 17, 2026.

How many recent filings does HRTX have?

Intrinsic Alpha currently shows 20 recent filings for HRTX.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.